Investor Type | Firm |
Type of Fund | Private Equity Fund |
Industries | Software (Web Marketplace Saas..) • BioTech • Businesses Solutions • Hardware (& Manufacturing) • Energy • CleanTech • HealthTech (& Fitness) • Food & Beverage • Logistics (& Distribution) |
Stages | Expansion, MBO/LBO, Recapitalization |
Investing | United States |
Bluehenge Capital Partners is a private equity fund headquartered at 152 West 57th Street, 20th Floor, New York, New York, 10019, United States, specializing in creative capital solutions for middle market businesses. With 25 years of experience as a team and $350 million invested across 46 investments, Bluehenge is committed to not only providing financial investments but also creating lasting partnerships that extend beyond the financial aspects to support future growth and community benefits. Bluehenge focuses on a variety of industries including industrial services, manufacturing, distribution, healthcare, business services, logistics, technology, consumer, software, BioTech, businesses solutions, hardware and manufacturing, energy, CleanTech, HealthTech and fitness, and food and beverage. They seek companies with $20M to $250M in revenue and $3M to $25M in EBITDA, whether they be family-owned, founder-led, or private equity-backed. Bluehenge offers investments ranging from $5M to $25M utilizing senior debt, junior debt, and equity to aid in growth, recapitalizations, refinancing, or buyouts. They also participate in the U.S. Small Business Administration's SBIC program, aiming to be a strategic and supportive partner through the right questions and understanding of business challenges and opportunities. Bluehenge targets investors such as banks, insurance companies, institutional investors, and family offices, and is known for their partnership approach, extensive experience, and purpose-driven strategies. They boast a robust portfolio and a professional team consisting of managing partners A. David Kocen, Nemo Viso, Albert Alexander III, Vice Presidents Robert Davis and Sean Martin, Senior Associate Cole Kendrick, and Associate Jaime Dasso.